Advertisement
Singapore markets open in 3 hours 19 minutes

  • Straits Times Index

    3,367.90
    +29.33 (+0.88%)
     

  • S&P 500

    5,509.01
    +33.92 (+0.62%)
     

  • Dow

    39,331.85
    +162.33 (+0.41%)
     

  • Nasdaq

    18,028.76
    +149.46 (+0.84%)
     

  • Bitcoin USD

    61,902.06
    -1,154.68 (-1.83%)
     

  • CMC Crypto 200

    1,332.23
    -12.28 (-0.91%)
     

  • FTSE 100

    8,121.20
    -45.56 (-0.56%)
     

  • Gold

    2,338.60
    -0.30 (-0.01%)
     

  • Crude Oil

    83.17
    -0.21 (-0.25%)
     

  • 10-Yr Bond

    4.4360
    -0.0430 (-0.96%)
     

  • Nikkei

    40,074.69
    +443.63 (+1.12%)
     

  • Hang Seng

    17,769.14
    +50.53 (+0.29%)
     

  • FTSE Bursa Malaysia

    1,597.96
    -0.24 (-0.02%)
     

  • Jakarta Composite Index

    7,125.14
    -7,139.63 (-50.05%)
     

  • PSE Index

    6,358.96
    -39.81 (-0.62%)
     

Sangamo: Q1 Earnings Snapshot

Associated Press Finance
·1-min read

BRISBANE, Calif. (AP) — BRISBANE, Calif. (AP) — Sangamo Therapeutics Inc. (SGMO) on Thursday reported a loss of $49.1 million in its first quarter.

On a per-share basis, the Brisbane, California-based company said it had a loss of 27 cents.

The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 22 cents per share.

The drug developer posted revenue of $481,000 in the period, also missing Street forecasts. Three analysts surveyed by Zacks expected $8.5 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SGMO at https://www.zacks.com/ap/SGMO